Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernewsroom.regeneron.com
Regeneron Pharmaceuticals Inc. News Releases
Get the latest updates from Regeneron Pharmaceuticals Inc. News Releases directly as they happen.
Follow now 133 followers
Latest posts
Last updated 8 days ago
Regeneron to Highlight Advances at ASCO with Phase 3 Adjuvant Libtayo® (cemiplimab) CSCC Updates and Promising Early Blood Cancer Data with Linvoseltamab Combination
8 days ago
18 presentations across five cancer types include new insights on the potential...
Dupixent® (dupilumab) Data Presented at ATS Reinforce Impact of Targeting Key Type 2 Inflammation Drivers to Improve Outcomes for Chronic Respiratory Diseases
8 days ago
24 abstracts, including 1 oral presentation and 4 late-breaking posters on Dupixent...
Regeneron Reports First Quarter 2025 Financial and Operating Results
11 days ago
First quarter 2025 revenues of $3.0 billion ; GAAP diluted EPS of...
Lynozyfic™ (linvoseltamab) Approved in the European Union for the Treatment of Relapsed/Refractory Multiple Myeloma
12 days ago
Approval of Lynozyfic is based on data showing deep and durable responses...
Lynozyfic™ (linvoseltamab) Approved in the European Union for the Treatment of Relapsed/Refractory Multiple Myeloma
12 days ago
Approval of Lynozyfic is based on data showing deep and durable responses...
EYLEA HD® (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Continued Safety and Efficacy and Highlight Early Real-World Outcomes for Patients with Serious Retinal Disease
12 days ago
Initial real-world data from nearly 40,000 EYLEA HD patients will provide early...
EYLEA HD® (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Continued Safety and Efficacy and Highlight Early Real-World Outcomes for Patients with Serious Retinal Disease
12 days ago
Initial real-world data from nearly 40,000 EYLEA HD patients will provide early...
Regeneron Announces New Investment in Manufacturing of its Industry-Leading Biologic Medicines
18 days ago
New manufacturing and supply agreement with FUJIFILM Diosynth Biotechnologies in North Carolina...
Regeneron Announces New Investment in Manufacturing of its Industry-Leading Biologic Medicines
18 days ago
New manufacturing and supply agreement with FUJIFILM Diosynth Biotechnologies in North Carolina...
Regeneron Announces Investor Conference Presentations
18 days ago
TARRYTOWN, N.Y. , April 21, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc...
Regeneron Announces Investor Conference Presentations
18 days ago
TARRYTOWN, N.Y. , April 21, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc...
Regeneron Provides Update on EYLEA HD® (aflibercept) Injection 8 mg Supplemental Biologics License Application
21 days ago
TARRYTOWN, N.Y. , April 18, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc...